According to GuruFocus’ Insider Data, these are the largest CEO buys during the past week.
OPKO CEO bought 1,235,000 shares
OPKO Health Inc. (OPK, Financial) CEO, Chairman and 10% owner Phillip Frost bought 1,235,000 shares during the past week.
Frost bought 10,000 shares for $7.52 per share on May 5; 100,000 shares for $7.22 per share on May 8; and 1,125,000 shares for $6.96 per share on May 10.
OPKO is a diversified health care company. Its operating business segments are diagnostics and pharmaceutical. The company has a market cap of $4.002 billion. Its shares traded at $7.19 with a price-earnings (P/E) ratio of -156.3 as of May 12.
Consolidated revenues for the three months ended March 31 were $296.1 million compared to $291.0 million from the comparable period of 2016.
Executive Vice President-Administration Steven D. Rubin bought 2,000 shares for $6.91 per share on May 11. The stock price has increased by 4.05% since.
Vice Chairman and Chief Technical Officer Jane Hsiao bought 40,000 shares for $6.97 per share on May 10 and 20,000 shares for $6.93 per share on May 11.
Plains GP CEO bought 100,000 shares
Plains GP Holdings LP (PAGP, Financial) Chairman and CEO Greg L. Armstrong bought 100,000 shares for $27.64 per share on May 10. The stock price has increased by 0.36% since.
Plains GP owns and operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids, natural gas and refined products. Its business segments are Transportation, Facilities and Supply and Logistics. The company has a market cap of $15.3 billion. Its shares traded at $27.74 with a P/E ratio of 29.51 as of May 12.
Net income for the first quarter was $444 million compared to $202 million of the prior-year period, a change of 120%.
Twilio CEO bought 100,000 shares
Twilio Inc. (TWLO, Financial) CEO and 10% owner Jeff Lawson bought 100,000 shares for $23.43 per share on May 10. The stock price has increased by 2.43% since.
Twilio is a communications platform-as-a-service company. It provides a cloud communications platform that enables developers to build, scale and operate communications within software applications through the cloud as a pay-as-you-go service. The company has a market cap of $2.17 billion. Its shares traded at $24 with a P/E ratio of -30.85 as of May 12.
Total revenue for the fourth quarter of 2016 was $82.0 million, up 60% from the fourth quarter of 2015.
Chief Financial Officer (CFO) Lee Kirkpatrick sold 10,000 shares for $30.42 per share on April 17. The stock price has decreased by 21.1% since.
Director James McGeever bought 10,000 shares for $23.19 per share on May 11. The stock price has increased by 3.49% since.
General Counsel and Secretary Karyn Smith sold 5,399 shares for $31.8 per share on April 19. The stock price has decreased by 24.53% since.
Tallgrass Energy Partners CEO bought 31,016 shares
Tallgrass Energy Partners LP (TEP, Financial) President and CEO David G. Dehaemers Jr. bought 31,016 shares during the past week at a price of $49.82.
Tallgrass Energy focuses on the operation, acquisition and development of natural gas and crude oil in North America. It is also engaged in natural gas processing, treating and fractionation facilities. The company has a market cap of $3.684 billion. Its shares traded at $50.28 with a P/E ratio of 22.55 as of May 12.
Net income for the first quarter was $70.905 million compared to $47.755 million from the prior-year period.
Dehaemers bought 26,016 shares for $49.83 per share on May 10 and 5,000 shares for $49.75 per share on May 11. The stock price has increased by 1.07% since.
Kite Pharma CEO bought 17,000 shares
Chairman, President and CEO of Kite Pharma Inc. (KITE, Financial) Arie Belldegrun bought 17,000 shares for $68.57 per share on May 9. The stock price has increased by 10% since.
Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. The company has a market cap of $4.265 billion. Its shares traded at $75.43 with a P/E ratio of -13.82 as of May 12.
Revenues for the first quarter of 2017 were $9.8 million.
CFO Paul L. Jenkinson bought 3,450 shares for $72.59 per share on May 10. The stock price has increased by 3.91% since.
Director David Bonderman bought 50,000 shares for $68.94 per share on May 9. The stock price has increased by 9.41% since.
Director Steven B. Ruchefsky bought 1,400 shares for $69.5 per share on May 9. The stock price has increased by 8.53% since.
Director Ran Nussbaum bought 9,832 shares for $69.11 per share on May 9. The stock price has increased by 9.14% since.
Executive Vice President Business Development Helen Susan Kim sold 2,400 shares for $82.12 per share on May 1. The stock price has decreased by 8.15% since.
Executive Vice President R&D and Chief Medical Officer David D. Chang sold 20,000 shares for $82.09 per share on May 1. The stock price has decreased by 8.11% since.
For the complete list of stocks that bought by their company CEOs, go to CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned in the article below.
Start a free seven-day trial of Premium Membership to GuruFocus.
